Core Scientific, Inc/tx Form 4 insider transactions

Director Jordan Levy purchased 62,500 shares of Core Scientific, Inc. common stock at a weighted average price of $8.0081 on March 6, 2025.

Director Todd A. Becker of Core Scientific, Inc. executed multiple sales of common stock and warrants on March 3rd and 4th, 2025.

Core Scientific director Eric Stanton Weiss acquired 20,448 shares of common stock through a restricted stock unit grant.

Director Jarrod M. Patten of Core Scientific, Inc. acquired 20,448 shares of common stock through a restricted stock unit grant.

Director Yadin Rozov of Core Scientific, Inc. acquired 20,448 shares through a restricted stock unit grant.

Director Jordan Levy of Core Scientific, Inc. acquired 20,448 shares of common stock through a restricted stock unit grant.

Core Scientific director Jeffrey David Booth acquired 20,448 shares through a restricted stock unit grant, which will vest on January 27, 2026.

Core Scientific director Todd Becker acquired 20,448 shares of common stock through a restricted stock unit grant that will vest on January 27, 2026.

Core Scientific's CEO, Adam Sullivan, sold 369,712 shares of common stock on January 24, 2025, to satisfy tax obligations related to vesting restricted stock units.

Todd M. Duchene, Chief Legal and Administrative Officer of Core Scientific, sold 25,277 shares of common stock on January 24, 2025, to satisfy tax obligations related to vesting restricted stock units.

Core Scientific's Chief Financial Officer, Denise Marie Brucia, sold 802 shares of common stock to cover tax obligations related to vesting restricted stock units.

Core Scientific's CEO, Adam Sullivan, acquired 159,306 shares through vesting of restricted stock units and sold 88,380 shares to cover tax obligations.

Core Scientific's Chief Legal and Administrative Officer, Todd DuChene, acquired shares through vesting of restricted stock units and subsequently sold a portion to cover tax obligations.

Core Scientific's Chief Legal and Administrative Officer, Todd DuChene, reports the acquisition and disposal of common stock and warrants.

Core Scientific's Chief Legal and Administrative Officer, Todd DuChene, acquired 196,977 shares and warrants at a nominal price, while also disposing of 1,858,451 shares.

A director of Core Scientific, Inc. sold 105,000 shares of common stock at an average price of $18.1138 per share on November 22, 2024.

Core Scientific's Chief Legal and Administrative Officer, Todd DuChene, sold 25,000 shares of common stock at an average price of $17.0968.

Core Scientific director Yadin Rozov acquired 195,000 shares of common stock and 195,000 Tranche 2 warrants at a price of $0.01 per share.

Denise Marie Brucia Sterling, CFO of Core Scientific, reports the acquisition of 318,613 shares of common stock via a restricted stock unit (RSU) grant and the disposal of 440,830 shares on September 5, 2024.

Director Jarrod M. Patten of Core Scientific, Inc. executed a transaction involving the acquisition and disposal of common stock on September 13, 2024.

Director Jarrod M Patten purchased 2,100 shares of Core Scientific, Inc. (CORZ) at $10.1 per share on September 11, 2024, increasing his direct holdings to 297,760 shares.

Director Jarrod M Patten of Core Scientific, Inc. purchased 2,100 shares of common stock at $9.90 per share on September 10, 2024, increasing his direct holdings to 295,660 shares.

Director Eric Stanton Weiss purchased 5,000 shares of Core Scientific, Inc. at $9.21 per share on September 9, 2024.

Director Jarrod M Patten purchased 7,800 shares of Core Scientific, Inc. (CORZ) at $9.28 per share on September 4, 2024, increasing his direct holdings to 293,560 shares.

Director Jarrod M. Patten of Core Scientific, Inc. purchased 5,021 shares of common stock at an average price of $9.6786 on September 3, 2024.

Director Jarrod M Patten of Core Scientific, Inc. recently acquired 1,500 shares of common stock at $9.95 per share, increasing his total holdings to 280,739 shares.

Director Jarrod M Patten of Core Scientific, Inc. purchased 4,000 shares of common stock at $9.7 per share on August 28, 2024.

Director Jordan Levy of Core Scientific, Inc. purchased 48,700 shares of common stock at an average price of $10.1957 on August 20, 2024.

CEO Adam Taylor Sullivan acquired shares and warrants of Core Scientific, Inc. in a transaction dated August 16, 2024.

Core Scientific's CFO, Denise Brucia Sterling, sold 8,752 shares of common stock on August 16, 2024, to satisfy tax obligations related to vesting restricted stock units.